Cardinal Health, US14149Y1082

Cardinal Health stock highlights supply chain resilience in October

Published on 10/07/2026 at 16:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock carries a fiscal 2027 consensus of USD 266.02 billion revenue and USD 12.55 adjusted EPS. First-quarter results are scheduled for November 5, 2026.

Belebtes NYSE-Handelsparkett mit Healthcare-Sektor-Anzeigetafeln und Tradern
NYSE-Börsenparkett mit Healthcare-Charts zeigt Cardinal Health Inc. Aktienhandel live – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health stock (ISIN US14149Y1082) was trading at USD 234.28 on the NYSE on October 7, 2026, with a daily change of 0.36 percent. The 52-week range stood at USD 151.87 to USD 258.30, placing the quote 9.3 percent below the yearly high. The latest company update puts supply-chain execution at the center of the investment case.

Distribution network faces disruptions

According to Chain Drug Review on October 6, 2026, Cardinal Health is highlighting the resilience of its Global Medical Products and Distribution business during National Healthcare Supply Chain Week.

The company said its infrastructure includes nearly 50 distribution and replenishment sites across North America. The update described contingency measures such as backup generators, satellite communications, alternative transportation routes and pre-contracted fuel suppliers.

Consensus points to higher earnings

Zacks reported on October 6, 2026, that fiscal 2027 revenue consensus stood at USD 266.02 billion, implying 4.6 percent growth from the year-ago reported figure. The consensus estimate for adjusted EPS was USD 12.55, an 11.5 percent increase from the prior year.

The company had reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13 percent to 15 percent in its October 1 release. That range corresponds to adjusted EPS of USD 12.40 to USD 12.60, while pharmaceutical profit growth is expected at 8 percent to 11 percent in fiscal 2027.

Price target remains above the quote

Moomoo listed 14 analysts as of September 30, 2026, with 85.71 percent Buy ratings and 14.29 percent Hold ratings. Its average 12-month price target was USD 270.00, with a USD 250.00 low and USD 292.00 high; the average target lies 15.2 percent above the October 7 quote.

For investors, the contrast is clear: the earnings framework points to double-digit adjusted EPS growth, while the stock remains 9.3 percent below its 52-week high. The next scheduled test arrives before the market opens on November 5, 2026.

Cardinal Health stock stays below yearly high

Cardinal Health stock was trading at USD 234.28 on the NYSE at 10:43 a.m. ET on October 7, 2026. Trading volume was 129,991 shares and market capitalization was USD 54.9 billion.

Cardinal Health stock facts

  • Company: Cardinal Health, Inc.
  • ISIN: US14149Y1082
  • Ticker: CAH
  • Trading venue: NYSE
  • Price (as of October 7, 2026, 10:43 a.m. ET): USD 234.28
  • Market capitalization: USD 54.9 billion (as of October 7, 2026)
  • 52-week range: USD 151.87-258.30 (as of October 7, 2026)
  • Sector / Industry: Healthcare / Medical Distribution

Upcoming dates for Cardinal Health stock

  • November 5, 2026: Fiscal 2027 first-quarter results before the NYSE open

More news and analyses on Cardinal Health stock

Disclaimer...

en | US14149Y1082 | CARDINAL HEALTH | boerse | 70256998 | bgmi